Cargando…

The Diagnostic Performance of Thyroid US in Each Category of the Bethesda System for Reporting Thyroid Cytopathology

We aimed to evaluate the diagnostic performance of thyroid ultrasonography (US) in each category of the Bethesda system and analyze false positive/negative findings using US. This retrospective study included 622 thyroid nodules in 592 patients. The sensitivity, specificity, negative predictive valu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, So Yoon, Hahn, Soo Yeon, Shin, Jung Hee, Ko, Eun Young, Oh, Young Lyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922578/ https://www.ncbi.nlm.nih.gov/pubmed/27348515 http://dx.doi.org/10.1371/journal.pone.0155898

Ejemplares similares

Histopathological Review of Diagnostic Categories of the Bethesda System for Reporting Thyroid Cytopathology – An Institutional Experience of 5 Years
por: Upadhyaya, Paricha, et al.
Publicado: (2019)

A study of malignancy rates in different diagnostic categories of the Bethesda system for reporting thyroid cytopathology: An institutional experience
por: Arul, P., et al.
Publicado: (2015)

Diagnostic accuracy of Bethesda system for reporting thyroid cytopathology: an institutional perspective
por: Naz, Samreen, et al.
Publicado: (2014)

Triage of patients with AUS/FLUS on thyroid cytopathology: effectiveness of the multimodal diagnostic techniques
por: Kim, Tae Hyuk, et al.
Publicado: (2016)

Diagnostic Accuracy of the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC): An Institution Experience
por: Rai, Karima, et al.
Publicado: (2023)

Associations between Bethesda categories and tumor characteristics of conventional papillary thyroid carcinoma
por: Park, Vivian Youngjean, et al.
Publicado: (2018)

Thyroid Nodules Cytopathology Applying the Bethesda System with Histopathological Correlation
por: Zarif, Hawazen A., et al.
Publicado: (2018)

The Bethesda System for Reporting Thyroid Cytopathology: A Cytohistological Study
por: Anand, Bakiarathana, et al.
Publicado: (2020)

Non-invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) Lowers the Risk of Malignancy in the Bethesda System for Reporting Thyroid Cytopathology Diagnostic Categories
por: Al-Maghrabi, Hatim, et al.
Publicado: (2022)

Cytological diagnosis of pediatric thyroid nodule in perspective of the Bethesda System for Reporting Thyroid Cytopathology
por: Pantola, Chayanika, et al.
Publicado: (2016)

Reproducibility of the Bethesda System for Reporting Thyroid Cytopathology: A Methodological Issue
por: Naderi, Mehdi, et al.
Publicado: (2019)

AI diagnosis of Bethesda category IV thyroid nodules
por: Yao, Jincao, et al.
Publicado: (2023)

Multimodality Molecular Imaging (FDG-PET/CT, US Elastography, and DWI-MRI) as Complimentary Adjunct for Enhancing Diagnostic Confidence in Reported Intermediate Risk Category Thyroid Nodules on Bethesda Thyroid Cytopathology Reporting System
por: Basu, Sandip, et al.
Publicado: (2016)

The Bethesda System for Reporting Thyroid Cytopathology: Validating at Tribhuvan University Teaching Hospital
por: Acharya, Kunjan, et al.
Publicado: (2021)

Repeat Diagnoses of Bethesda Category III Thyroid Nodules: What To Do Next?
por: Yoo, Mi Ri, et al.
Publicado: (2015)

Modified Bethesda system informing cytopathologic adequacy improves malignancy risk stratification in nodules considered benign or atypia(follicular lesion) of undetermined significance
por: Lee, You-Bin, et al.
Publicado: (2018)

A Different Perspective on Evaluating the Malignancy Rate of the Non-Diagnostic Category of the Bethesda System for Reporting Thyroid Cytopathology: A Single Institute Experience and Review of the Literature
por: Gunes, Pembegul, et al.
Publicado: (2016)

Reproducibility of “The Bethesda System for Reporting Thyroid Cytopathology:” A Retrospective Analysis of 107 Patients
por: Awasthi, Pragati, et al.
Publicado: (2018)

The Use of the Bethesda System for Reporting Thyroid Cytopathology in Korea: A Nationwide Multicenter Survey by the Korean Society of Endocrine Pathologists
por: Kim, Mimi, et al.
Publicado: (2017)

Evaluation of thyroid nodules classified as Bethesda category III on FNAC
por: Garg, Shiwani, et al.
Publicado: (2017)

Predictors of Malignancy in Thyroid Nodules Classified as Bethesda Category III
por: Liu, Xiaoli, et al.
Publicado: (2022)

Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features and Its Impact on the Risk of Malignancy in the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience
por: Kim, Milim, et al.
Publicado: (2018)

Diagnostic Efficacy of BRAFV600E Immunocytochemistry in Thyroid Aspirates in Bethesda Category IV and Papillary Thyroid Carcinoma
por: Anand, Nidhi, et al.
Publicado: (2021)

Thyroid Cytopathology Reporting by the Bethesda System: A Two-Year Prospective Study in an Academic Institution
por: Mehra, Payal, et al.
Publicado: (2015)

Real-world EUROCRINE(®) registry data challenge the reliability of Bethesda cytopathology for thyroid surgery indication
por: Staubitz, Julia I., et al.
Publicado: (2021)

Does the Bethesda category predict aggressive features in differentiated thyroid cancer?
por: Lima, Ana Rafaela Lopes Reis, et al.
Publicado: (2019)

Correlation between Thyroid Imaging Reporting and Data System and Bethesda System of Reporting of Thyroid Cytopathology of Thyroid Nodule: A Single Center Experience
por: Biswas, Ananya, et al.
Publicado: (2020)

Fine Needle Aspiration of Thyroid Nodules Using the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience in a Rural Setting
por: Guo, Aili, et al.
Publicado: (2017)

The Bethesda system for reporting thyroid cytopathology in Colombia: Correlation with histopathological diagnoses in oncology and non-oncology institutions
por: Melo-Uribe, Mario Alexander, et al.
Publicado: (2015)

The 2023 Bethesda system for reporting thyroid cytopathology: novi sub sole, subdivision is no more debatable, in thyroidology
por: Sengul, Ilker, et al.
Publicado: (2023)

Comparison Between Fine Needle Aspiration and Core Needle Biopsy for the Diagnosis of Thyroid Nodules: Effective Indications According to US Findings
por: Hahn, Soo Yeon, et al.
Publicado: (2020)

The Bethesda System thyroid diagnostic categories in the African-American population in conjunction with surgical pathology follow-up
por: Archuletta, Pamela Anne, et al.
Publicado: (2012)

Cytomorphologic features distinguishing Bethesda category IV thyroid lesions from parathyroid
por: Sung, Simon, et al.
Publicado: (2017)

Malignancy rate of Bethesda category III thyroid nodules according to ultrasound risk stratification system and cytological subtype
por: Yoo, Won Sang, et al.
Publicado: (2020)

The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC): A report of 2,781 cases in a Chinese population
por: Zhu, Yanli, et al.
Publicado: (2020)

ODP481 Frequency and outcomes of reporting Bethesda class III thyroid cytopathology- An integrated health network's experience
por: Dantey, Kossivi, et al.
Publicado: (2022)

Thyroid Cancer Detection Rate and Associated Risk Factors in Patients with Thyroid Nodules Classified As Bethesda Category III
por: Mileva, Magdalena, et al.
Publicado: (2018)

Evaluation of thyroid lesions by fine-needle aspiration cytology based on Bethesda system for reporting thyroid cytopathology classification among the population of South Bihar
por: Bhartiya, Richa, et al.
Publicado: (2016)

Hashimoto’s Thyroiditis Does Not Influence the Malignancy Risk in Nodules of Category III in the Bethesda System
por: Słowińska-Klencka, Dorota, et al.
Publicado: (2022)

Malignancy in Thyroid Nodules with Bethesda III Category on Repeat Fine Needle Aspiration Biopsy*
por: Lourdes Ng, Jennifer, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3egekt4c3jd1uj15caj9ompnsr